TM
Tarik Mekhail
Medical Oncologist · AdventHealth Florida
Credentials: · · · · ·
History
Present
- 1987–1989
Medical Oncology
- 1984–1987
Internal Medicine
- 1980–1984
Doctor of Medicine
Research
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2017 · 3,824 citations
First-line crizotinib versus chemotherapy in ALK-positive lung cancer
New England Journal of Medicine · 2014 · 2,629 citations
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
New England Journal of Medicine · 2018 · 2,311 citations
- RB
30 papers
15 papers
12 papers
9 papers
9 papers · 7 as a resident
- MS
9 papers
- TO
8 papers
7 papers
Clinical trials
- 2004–2007
Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors
Study chair · Completed · Phase 1
The Cleveland Clinic